{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T18:21:22Z","timestamp":1773512482760,"version":"3.50.1"},"reference-count":103,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008431","name":"Consejer\u00eda de Educaci\u00f3n, Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Chromatin is dynamically remodeled to adapt to all DNA-related processes, including DNA damage responses (DDR). This adaptation requires DNA and histone epigenetic modifications, which are mediated by several types of enzymes; among them are lysine methyltransferases (KMTs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>KMT inhibitors, chaetocin and tazemetostat (TZM), were used to study their role in the DDR induced by ionizing radiation or doxorubicin in two human sarcoma cells lines. The effect of these KMT inhibitors was tested by the analysis of chromatin epigenetic modifications, H4K16ac and H4K20me2. DDR was monitored by the formation of \u03b3H2AX, MDC1, NBS1 and 53BP1 foci, and the induction of apoptosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Chaetocin and tazemetostat treatments caused a significant increase of H4K16 acetylation, associated with chromatin relaxation, and increased DNA damage, detected by the labeling of free DNA-ends. These inhibitors significantly reduced H4K20 dimethylation levels in response to DNA damage and impaired the recruitment of 53BP1, but not of MDC1 and NBS1, at DNA damaged sites. This modification of epigenetic marks prevents DNA repair by the NHEJ pathway and leads to cell death.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>KMT inhibitors could function as sensitizers to DNA damage-based therapies and be used in novel synthetic lethality strategies for sarcoma treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcell.2021.715126","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T07:40:43Z","timestamp":1630741243000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Lysine Methyltransferase Inhibitors Impair H4K20me2 and 53BP1 Foci in Response to DNA Damage in Sarcomas, a Synthetic Lethality Strategy"],"prefix":"10.3389","volume":"9","author":[{"given":"Ignacio","family":"Campillo-Marcos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Monte-Serrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Navarro-Carrasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal","family":"Garc\u00eda-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro A.","family":"Lazo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.dnarep.2015.09.002","article-title":"Chromatin perturbations during the DNA damage response in higher eukaryotes.","volume":"36","author":"Bakkenist","year":"2015","journal-title":"DNA Repair"},{"key":"B2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ceb.2011.03.012","article-title":"Damage site chromatin: open or closed?","volume":"23","author":"Ball","year":"2011","journal-title":"Curr. Opin. Cell Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1056\/NEJMra1805035","article-title":"Epigenetic therapies for cancer.","volume":"383","author":"Bates","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017905","article-title":"Nucleosome remodeling and epigenetics.","volume":"5","author":"Becker","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.dnarep.2010.09.010","article-title":"Assembly and function of DNA double-strand break repair foci in mammalian cells.","volume":"9","author":"Bekker-Jensen","year":"2010","journal-title":"DNA Repair"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.cell.2006.10.043","article-title":"Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair.","volume":"127","author":"Botuyan","year":"2006","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1158\/1535-7163.MCT-16-0840","article-title":"EZH2 inhibition by tazemetostat results in altered dependency on B-cell activation signaling in DLBCL.","volume":"16","author":"Brach","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"B8","author":"Bremer","year":"2009","journal-title":"Statistics at the Bench: A Step-By Step Handbook for Biologists."},{"key":"B9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/35002510","article-title":"Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA.","volume":"403","author":"Bruner","year":"2000","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2010.03.012","article-title":"53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks.","volume":"141","author":"Bunting","year":"2010","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.canlet.2020.12.032","article-title":"The human VRK1 chromatin kinase in cancer biology.","volume":"503","author":"Campillo-Marcos","year":"2021","journal-title":"Cancer Lett."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1204-1","article-title":"Olaparib and ionizing radiation trigger a cooperative DNA-damage repair response that is impaired by depletion of the VRK1 chromatin kinase.","volume":"38","author":"Campillo-Marcos","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10741-9","article-title":"Poly(ADP-ribose) polymerase-1 antagonizes DNA resection at double-strand breaks.","volume":"10","author":"Caron","year":"2019","journal-title":"Nat. Commun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1172\/JCI123319","article-title":"PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer.","volume":"129","author":"Chabanon","year":"2019","journal-title":"J. Clin. Invest."},{"key":"B15","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/leu.2011.271","article-title":"Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1.","volume":"26","author":"Chaib","year":"2012","journal-title":"Leukemia"},{"key":"B16","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41586-019-1102-x","article-title":"WRN helicase is a synthetic lethal target in microsatellite unstable cancers.","volume":"568","author":"Chan","year":"2019","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nchembio.1187","article-title":"Chaetocin is a nonspecific inhibitor of histone lysine methyltransferases.","volume":"9","author":"Cherblanc","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molcel.2010.09.019","article-title":"The DNA damage response: making it safe to play with knives.","volume":"40","author":"Ciccia","year":"2010","journal-title":"Mol. Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1083\/jcb.201012132","article-title":"PARP regulates nonhomologous end joining through retention of Ku at double-strand breaks.","volume":"194","author":"Couto","year":"2011","journal-title":"J. Cell Biol."},{"key":"B20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nrc2440","article-title":"Living on a break: cellular senescence as a DNA-damage response.","volume":"8","author":"d\u2019Adda di Fagagna","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1002\/cncr.32795","article-title":"Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: a propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.","volume":"126","author":"D\u2019Ambrosio","year":"2020","journal-title":"Cancer"},{"key":"B22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy.","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00412-011-0358-1","article-title":"Epigenetic regulation of genomic integrity.","volume":"121","author":"Deem","year":"2012","journal-title":"Chromosoma"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1021\/acs.biochem.5b01210","article-title":"Role of histone-modifying enzymes and their complexes in regulation of chromatin biology.","volume":"55","author":"DesJarlais","year":"2016","journal-title":"Biochemistry"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.179","article-title":"Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolism.","volume":"5","author":"Dixit","year":"2014","journal-title":"Cell Death Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/13543776.2021.1841167","article-title":"Targeting PRC2 for the treatment of cancer: an updated patent review (2016 - 2020).","volume":"31","author":"Dockerill","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.15252\/embr.201439434","article-title":"SET8 methyltransferase activity during the DNA double-strand break response is required for recruitment of 53BP1.","volume":"15","author":"Dulev","year":"2014","journal-title":"EMBO Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1158\/1535-7163.MCT-09-0201","article-title":"Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90.","volume":"8","author":"Dungey","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"B29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1139\/o97-043","article-title":"Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death.","volume":"75","author":"Duriez","year":"1997","journal-title":"Biochem. Cell Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1111\/j.1432-1033.2004.04162.x","article-title":"Chromatin dynamics at DNA replication, transcription and repair.","volume":"271","author":"Ehrenhofer-Murray","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1074\/jbc.M807375200","article-title":"The direct interaction between 53BP1 and MDC1 is required for the recruitment of 53BP1 to sites of damage.","volume":"284","author":"Eliezer","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1200\/JCO.2009.26.9589","article-title":"Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval.","volume":"28","author":"Fong","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12318","article-title":"53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark.","volume":"499","author":"Fradet-Turcotte","year":"2013","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102986","article-title":"VRK1 phosphorylates Tip60\/KAT5 and is required for H4K16 acetylation in response to DNA damage.","volume":"12","author":"Garcia-Gonzalez","year":"2020","journal-title":"Cancers"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S1470-2045(20)30451-4","article-title":"Tazemetostat in advanced epithelioid sarcoma with loss of INI1\/SMARCB1: an international, open-label, phase 2 basket study.","volume":"21","author":"Gounder","year":"2020","journal-title":"Lancet Oncol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nchembio721","article-title":"Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9.","volume":"1","author":"Greiner","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175950","article-title":"Chaetocin induces apoptosis in human melanoma cells through the generation of reactive oxygen species and the intrinsic mitochondrial pathway, and exerts its anti-tumor activity in vivo.","volume":"12","author":"Han","year":"2017","journal-title":"PLoS One"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1101\/gad.307702.117","article-title":"Chromatin and nucleosome dynamics in DNA damage and repair.","volume":"31","author":"Hauer","year":"2017","journal-title":"Genes Dev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.3892\/or.2017.5921","article-title":"Chaetocin induces cell cycle arrest and apoptosis by regulating the ROS-mediated ASK-1\/JNK signaling pathways.","volume":"38","author":"He","year":"2017","journal-title":"Oncol. Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1158\/1078-0432.CCR-19-2000","article-title":"Restoration of temozolomide sensitivity by PARP inhibitors in mismatch repair deficient glioblastoma is independent of base excision repair.","volume":"26","author":"Higuchi","year":"2020","journal-title":"Clin. Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/35077232","article-title":"Genome maintenance mechanisms for preventing cancer.","volume":"411","author":"Hoeijmakers","year":"2001","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/jmcb\/mjs066","article-title":"Histone H4 deacetylation facilitates 53BP1 DNA damage signaling and double-strand break repair.","volume":"5","author":"Hsiao","year":"2013","journal-title":"J. Mol. Cell Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1182\/blood-2006-07-027326","article-title":"Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress.","volume":"109","author":"Isham","year":"2007","journal-title":"Blood"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00868-4","article-title":"Targeting epigenetics in sarcomas through EZH2 inhibition.","volume":"13","author":"Italiano","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S1470-2045(18)30145-1","article-title":"Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study.","volume":"19","author":"Italiano","year":"2018","journal-title":"Lancet Oncol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1021\/ja101280p","article-title":"Total synthesis of (+)-chaetocin and its analogues: their histone methyltransferase G9a inhibitory activity.","volume":"132","author":"Iwasa","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease.","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.molcel.2016.03.031","article-title":"The TIP60 complex regulates bivalent chromatin recognition by 53BP1 through direct H4K20me binding and H2AK15 acetylation.","volume":"62","author":"Jacquet","year":"2016","journal-title":"Mol. Cell."},{"key":"B49","doi-asserted-by":"publisher","first-page":"157.e6","DOI":"10.1016\/j.ccell.2019.12.015","article-title":"EZH2 inhibition sensitizes CARM1-high, homologous recombination proficient ovarian cancers to PARP inhibition.","volume":"37","author":"Karakashev","year":"2020","journal-title":"Cancer Cell"},{"key":"B50","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.isci.2019.02.006","article-title":"Werner syndrome helicase is required for the survival of cancer cells with microsatellite instability.","volume":"13","author":"Kategaya","year":"2019","journal-title":"iScience"},{"key":"B51","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function.","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/B978-0-12-380866-0.60002-2","article-title":"DNA methylation and cancer.","volume":"70","author":"Kulis","year":"2010","journal-title":"Adv. Genet."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.37","article-title":"The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells.","volume":"5","author":"Lai","year":"2015","journal-title":"Blood Cancer J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.3390\/biom5042877","article-title":"ATM-dependent phosphorylation of all three members of the mrn complex: from sensor to adaptor.","volume":"5","author":"Lavin","year":"2015","journal-title":"Biomolecules"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1158\/1535-7163.MCT-13-0338","article-title":"Combining PARP-1 inhibition and radiation in Ewing sarcoma results in lethal DNA damage.","volume":"12","author":"Lee","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1634\/theoncologist.2015-0319","article-title":"Phase II study of olaparib (AZD-2281) after standard systemic therapies for disseminated colorectal cancer.","volume":"21","author":"Leichman","year":"2016","journal-title":"Oncologist"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5413-y","article-title":"Phase I\/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol.","volume":"19","author":"Lesueur","year":"2019","journal-title":"BMC Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"11951","DOI":"10.1074\/jbc.M117.788224","article-title":"Cross-talk between the H3K36me3 and H4K16ac histone epigenetic marks in DNA double-strand break repair.","volume":"292","author":"Li","year":"2017","journal-title":"J. Biol. Chem."},{"key":"B59","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.1039\/c9cp05635a","article-title":"Computational approaches to studying methylated H4K20 recognition by DNA repair factor 53BP1.","volume":"22","author":"Li","year":"2020","journal-title":"Phys. Chem. Chem. Phys."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3892\/ol.2019.10507","article-title":"Chaetocin induces caspase-dependent apoptosis in ovarian cancer cells via the generation of reactive oxygen species.","volume":"18","author":"Li","year":"2019","journal-title":"Oncol. Lett."},{"key":"B61","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.7150\/jca.32803","article-title":"Identification of Chaetocin as a Potent non-ROS-mediated anticancer drug candidate for gastric Cancer.","volume":"10","author":"Liao","year":"2019","journal-title":"J. Cancer"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.43333","article-title":"Werner syndrome helicase is a selective vulnerability of microsatellite instability-high tumor cells.","volume":"8","author":"Lieb","year":"2019","journal-title":"eLife"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1093\/nar\/gkr1296","article-title":"Structural mechanism of the phosphorylation-dependent dimerization of the MDC1 forkhead-associated domain.","volume":"40","author":"Liu","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s10495-015-1167-4","article-title":"Chaetocin induces endoplasmic reticulum stress response and leads to death receptor 5-dependent apoptosis in human non-small cell lung cancer cells.","volume":"20","author":"Liu","year":"2015","journal-title":"Apoptosis"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1073\/pnas.1222617110","article-title":"Role of 53BP1 oligomerization in regulating double-strand break repair.","volume":"110","author":"Lottersberger","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B66","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.molcel.2005.11.025","article-title":"MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals.","volume":"21","author":"Lou","year":"2006","journal-title":"Mol. Cell."},{"key":"B67","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1200\/JCO.2008.19.2930","article-title":"Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas.","volume":"27","author":"Maurel","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1158\/1541-7786.MCR-16-0108","article-title":"Olaparib, monotherapy or with ionizing radiation, exacerbates DNA damage in normal tissues: insights from a new p21 reporter mouse.","volume":"14","author":"McMahon","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1101\/gad.333237.119","article-title":"53BP1: a DSB escort.","volume":"34","author":"Mirman","year":"2020","journal-title":"Genes Dev."},{"key":"B70","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.bbamcr.2016.02.005","article-title":"VRK1 phosphorylates and protects NBS1 from ubiquitination and proteasomal degradation in response to DNA damage.","volume":"1863","author":"Monsalve","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1007\/s00018-018-2746-7","article-title":"VRK1 and AURKB form a complex that cross inhibit their kinase activity and the phosphorylation of histone H3 in the progression of mitosis.","volume":"76","author":"Moura","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/ncb1343","article-title":"Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks.","volume":"8","author":"Murr","year":"2006","journal-title":"Nat. Cell. Biol."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.683038","article-title":"VRK1 depletion facilitates the synthetic lethality of temozolomide and olaparib in glioblastoma cells.","volume":"9","author":"Navarro-Carrasco","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2107-y","article-title":"The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma.","volume":"10","author":"Ozyerli-Goknar","year":"2019","journal-title":"Cell Death Dis."},{"key":"B75","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrm3719","article-title":"Double-strand break repair: 53BP1 comes into focus.","volume":"15","author":"Panier","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"228","DOI":"10.18632\/oncotarget.443","article-title":"Regulation of p53: a collaboration between Mdm2 and Mdmx.","volume":"3","author":"Pei","year":"2012","journal-title":"Oncotarget"},{"key":"B77","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nature09658","article-title":"MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites.","volume":"470","author":"Pei","year":"2011","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1091\/mbc.E15-02-0076","article-title":"Empowering statistical methods for cellular and molecular biologists.","volume":"30","author":"Pollard","year":"2019","journal-title":"Mol. Biol. Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jmb.2014.05.025","article-title":"Reshaping chromatin after DNA damage: the choreography of histone proteins.","volume":"427","author":"Polo","year":"2015","journal-title":"J. Mol. Biol."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-017-0480-2","article-title":"PARP inhibitors in prostate cancer.","volume":"18","author":"Ramakrishnan Geethakumari","year":"2017","journal-title":"Curr. Treat. Options. Oncol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation.","volume":"377","author":"Robson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.03.042","article-title":"Epigenetic therapy for epithelioid sarcoma.","volume":"181","author":"Rothbart","year":"2020","journal-title":"Cell"},{"key":"B83","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/15592294.2015.1028708","article-title":"VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damage.","volume":"10","author":"Salzano","year":"2015","journal-title":"Epigenetics"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.18632\/oncotarget.1678","article-title":"Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response.","volume":"5","author":"Salzano","year":"2014","journal-title":"Oncotarget"},{"key":"B85","doi-asserted-by":"publisher","first-page":"23757","DOI":"10.1074\/jbc.M112.353102","article-title":"Vaccinia-related Kinase 1 (VRK1) is an upstream nucleosomal kinase required for the assembly of 53BP1 foci in response to ionizing radiation-induced DNA damage.","volume":"287","author":"Sanz-Garcia","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/nprot.2007.202","article-title":"Extraction, purification and analysis of histones.","volume":"2","author":"Shechter","year":"2007","journal-title":"Nat. Protoc."},{"key":"B87","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mrfmmm.2017.07.011","article-title":"Regulation of repair pathway choice at two-ended DNA double-strand breaks.","author":"Shibata","year":"2017","journal-title":"Mutat. Res."},{"key":"B88","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1146\/annurev.biochem.75.103004.142422","article-title":"Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression.","volume":"75","author":"Shilatifard","year":"2006","journal-title":"Annu. Rev. Biochem."},{"key":"B89","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1023\/a:1016119328968","article-title":"Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update.","volume":"7","author":"Soldani","year":"2002","journal-title":"Apoptosis"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.4155\/fmc-2016-0096","article-title":"Recently discovered EZH2 and EHMT2 (G9a) inhibitors.","volume":"8","author":"Soumyanarayanan","year":"2016","journal-title":"Future Med. Chem."},{"key":"B91","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00280-017-3401-y","article-title":"Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition.","volume":"80","author":"Srinivasan","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nsmb.2499","article-title":"Acetylation limits 53BP1 association with damaged chromatin to promote homologous recombination.","volume":"20","author":"Tang","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1158\/1078-0432.CCR-15-0088","article-title":"Development of olaparib for BRCA-deficient recurrent epithelial ovarian cancer.","volume":"21","author":"Tewari","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1089\/ARS.2008.2318","article-title":"The anticancer agent chaetocin is a competitive substrate and inhibitor of thioredoxin reductase.","volume":"11","author":"Tibodeau","year":"2009","journal-title":"Antioxid. Redox. Signal."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0596-9","article-title":"Epigenetics in cancer stem cells.","volume":"16","author":"Toh","year":"2017","journal-title":"Mol. Cancer"},{"key":"B96","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrm1737","article-title":"The histone code at DNA breaks: a guide to repair?.","volume":"6","author":"van Attikum","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/35056049","article-title":"Chromosomal stability and the DNA double-stranded break connection.","volume":"2","author":"van Gent","year":"2001","journal-title":"Nat. Rev. Genet."},{"key":"B98","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1038\/emboj.2012.50","article-title":"Bat3 facilitates H3K79 dimethylation by DOT1L and promotes DNA damage-induced 53BP1 foci at G1\/G2 cell-cycle phases.","volume":"31","author":"Wakeman","year":"2012","journal-title":"EMBO J."},{"key":"B99","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1017\/S0033583513000085","article-title":"Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases.","volume":"46","author":"Wang","year":"2013","journal-title":"Q. Rev. Biophys."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2035-x","article-title":"ROS-mediated inactivation of the PI3K\/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin.","volume":"10","author":"Wen","year":"2019","journal-title":"Cell Death Dis."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccell.2020.10.015","article-title":"Molecular features of cancers exhibiting exceptional responses to treatment.","volume":"39","author":"Wheeler","year":"2021","journal-title":"Cancer Cell"},{"key":"B102","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature18951","article-title":"The structural basis of modified nucleosome recognition by 53BP1.","volume":"536","author":"Wilson","year":"2016","journal-title":"Nature"},{"key":"B103","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41580-020-00297-8","article-title":"The molecular basis and disease relevance of non-homologous DNA end joining.","volume":"21","author":"Zhao","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.715126\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T07:40:52Z","timestamp":1630741252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.715126\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":103,"alternative-id":["10.3389\/fcell.2021.715126"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.715126","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"article-number":"715126"}}